首页> 美国卫生研究院文献>Caspian Journal of Internal Medicine >A brief review of the latest pharmacological treatments of COVID-19
【2h】

A brief review of the latest pharmacological treatments of COVID-19

机译:简要介绍Covid-19的最新药理治疗方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

New Coronavirus which is called 2019-nCoV (2019-Novel-Coronavirus) or SARS-Cov-2 (Severe Acute respiratory Syndrome-Coronavirus 2) causes deadly pneumonia that first appeared in December 2019 in Wuhan city in China. This virus spreads all over the world quickly and made several problems for the community and healthcare system. Several drugs have been tried to manage COVID-19; however, our knowledge of this virus is not complete. At any rate, effective treatment or vaccine for this disease has not been discovered yet. Furthermore, to achieve this goal, more studies are needed on the structure of the virus and its pathogenesis mechanism. In this article, we summarized several articles suggesting treatments of COVID-19.
机译:新的冠状病毒称为2019-NCOV(2019年 - 新型冠状病毒)或SARS-COV-2(严重急性呼吸综合征 - 冠状病毒2)导致致命的肺炎,该肺炎于2019年12月在中国的武汉市。这种病毒迅速传播世界各地,并对社区和医疗保健系统产生了几个问题。有几种药物已经试图管理Covid-19;但是,我们对这种病毒的了解并不完整。在任何速率下,尚未发现这种疾病的有效治疗或疫苗。此外,为了实现这一目标,对病毒结构以及其发病机制需要更多的研究。在本文中,我们总结了几篇文章,旨在治疗Covid-19。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号